Discovery and the structural basis of a novel p21-activated kinase 4 inhibitor
Ryu, B.J., Kim, S., Min, B., Kim, K.Y., Lee, J.S., Park, W.J., Lee, H., Kim, S.H., Park, S.(2014) Cancer Lett 
- PubMed: 24704155 
- DOI: 10.1016/j.canlet.2014.03.024
- Primary Citation of Related Structures:  
4NJD - PubMed Abstract: 
Functional versatility and elevated expression in cancers have endowed p21-activated kinase 4 (PAK4) as one of the first-in-class anti-cancer drug target. In this study, a novel PAK4 inhibitor, KY-04031 (N(2)-(2-(1H-indol-3-yl)ethyl)-N(4)-(1H-indazol-5-yl)-6-methoxy-1,3,5-triazine-2,4-diamine), was discovered using a high-throughput screening ...